Surgical Technology
RYGB surgery is effective treatment for type 2 diabetes mellitus in morbidly obese
Published in Obesity and Diabetes Week, January 30th, 2006
According to recent research from the United States, "Type 2 diabetes mellitus (T2DM) has a very strong association with obesity. The aim of our study was to analyze the effects of Roux-en-Y gastric bypass (RYGB) surgery on the glucose metabolism in morbidly obese patients with T2DM."
A. Torquati and colleagues at Vanderbilt University explained, "Morbidly obese patients (n=117) with T2DM underwent measurements of fasting serum glucose and glycosylated hemoglobin (HbA1C ) at baseline, 6 months, and 12 months after...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Clinical Trials
Rosiglitazone increases sc adipose tissue glucose uptake in parallel with perfusion - Diabetes Pathogenesis
Inflammatory mediators by abdominal adipose tissue may link obesity and insulin resistance - Diabetes Pathogenesis
PPARalpha activation increases AdipoR and reduces inflammation in adipose tissue - Obesity Pathogenesis
Activation of cAMP or PPARgamma pathway increases oxidation in white adipocytes - Apoptosis
Alcohol stimulates activated hepatic apoptosis in genetically obese mice - Cardiology
JAK2/STAT is hyperactivated in obese/insulin resistant vascular tissue - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
